Literature DB >> 3749450

Natural history of diabetes presenting age 40-69 years: a prospective study of the influence of intensive dietary therapy.

D R Hadden, A L Blair, E A Wilson, D M Boyle, A B Atkinson, A L Kennedy, K D Buchanan, J D Merrett, D A Montgomery, J A Weaver.   

Abstract

Two hundred and twenty-three newly-diagnosed symptomatic diabetic patients with onset age 40-69 years enrolled in a prospective study of intensive dietary management of diabetes were observed for a period of six years and the data obtained is analysed. The variables studied were weight and fasting levels of plasma glucose and insulin, and of serum total cholesterol and triglyceride. These tests were monitored throughout the study and in addition the oral glucose tolerance test was analysed at entry to the study, after six months intensive dietary management and again after 72 months. Blood pressure, electrocardiogram and the presence of posterior tibial artery pulsation were recorded at entry to the study and at 36 months and 72 months. Approximately 80 per cent of the patients were managed solely by dietary restriction for the entire six years, but 25 patients received oral hypoglycaemic drugs and 26 required insulin treatment. Weight, and fasting glucose and triglyceride values fell in the first few months of intensive dietary management. Analysis of possible risk factors in survivors and patients dead at six years showed no significant differences, apart from a higher mean age at diagnosis in those who died. During the six years of intensive dietary management the mortality from all causes in these diabetic patients was no greater than that for the general population of Northern Ireland.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3749450

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  9 in total

1.  Changes in patient weight and the impact of antidiabetic therapy during the first 5 years after diagnosis of diabetes mellitus.

Authors:  N de Fine Olivarius; A H Andreasen; V Siersma; B Richelsen; H Beck-Nielsen
Journal:  Diabetologia       Date:  2006-07-14       Impact factor: 10.122

2.  Long-term effects of glipizide on insulin secretion and blood glucose control in patients with non-insulin-dependent diabetes mellitus.

Authors:  P O Bitzén; A Melander; B Scherstén; M Svensson; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1992       Impact factor: 2.953

Review 3.  The efficacy of aldose reductase inhibitors in the management of diabetic complications. Comparison with intensive insulin treatment and pancreatic transplantation.

Authors:  J M van Gerven; A M Tjon-A-Tsien
Journal:  Drugs Aging       Date:  1995-01       Impact factor: 3.923

4.  Assessment of dietary practice among diabetic patients in the United arab emirates.

Authors:  Juma Al-Kaabi; Fatma Al-Maskari; Hussein Saadi; Bachar Afandi; Hasratali Parkar; Nicolaas Nagelkerke
Journal:  Rev Diabet Stud       Date:  2008-08-10

5.  The use of biosimulation in the design of a novel multilevel weight loss maintenance program for overweight children.

Authors:  Denise E Wilfley; Dorothy J Van Buren; Kelly R Theim; Richard I Stein; Brian E Saelens; Farkad Ezzet; Angela C Russian; Michael G Perri; Leonard H Epstein
Journal:  Obesity (Silver Spring)       Date:  2010-02       Impact factor: 5.002

Review 6.  Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.

Authors:  A Melander; P O Bitzén; O Faber; L Groop
Journal:  Drugs       Date:  1989-01       Impact factor: 9.546

7.  Maternal blood glucose and the baby. The origins of the hyperglycaemia and pregnancy outcome study The Scott-Heron Lecture at the Royal Victoria Hospital--17 January 2001.

Authors:  D R Hadden
Journal:  Ulster Med J       Date:  2001-11

8.  Disease oriented medicine: the metabolic model.

Authors:  D R Hadden
Journal:  Ulster Med J       Date:  1996-05

9.  Characteristics associated with maintenance of mean A1C<6.5% in people with dysglycemia in the ORIGIN trial.

Authors: 
Journal:  Diabetes Care       Date:  2013-05-08       Impact factor: 19.112

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.